Internal Medicine, Gastroenterology · Norfolk, VA
NPI
1962488668
Since 2005
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
885 Kempsville Rd, Suite 114
Norfolk, VA, 23502
Phone (757) 466-0165
Groups this clinician bills Medicare through
Medicare paid, 2024
$222K
1,581 services
Medicare patients, 2024
904
Average age 74
Drug cost, 2024
$1.7M
1,856 prescriptions
Company payments, 2025
$86K
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael J Ryan was code 99214 (office e&m - established), 391 times for 281 patients. In total Michael J Ryan billed 1,581 services in 44 codes, and Medicare paid $222K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-08-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 391 | 281 | $92.31 | $36K |
| 99213 Office E&M - Established | Office | 160 | 137 | $62.22 | $9,955 |
| 99232 Hospital E&M - Subsequent | Facility | 117 | 90 | $61.17 | $7,156 |
| 45380 Lower GI Endoscopy - Other | Office | 78 | 78 | $288.44 | $22K |
| 43239 Upper GI Endoscopy | Office | 77 | 76 | $276.91 | $21K |
| 99223 Hospital E&M - Initial | Facility | 77 | 76 | $130.72 | $10K |
| 99233 Hospital E&M - Subsequent | Facility | 76 | 47 | $96.14 | $7,306 |
| 45385 Colonoscopy - Lesion Removal | Office | 75 | 75 | $396.67 | $30K |
| 43239 Upper GI Endoscopy | Facility | 57 | 57 | $78.89 | $4,497 |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Office | 44 | 44 | $332.42 | $15K |
| 99215 Office E&M - Established | Office | 37 | 32 | $132.30 | $4,895 |
| 45380 Lower GI Endoscopy - Other | Facility | 35 | 35 | $122.19 | $4,277 |
| 99222 Hospital E&M - Initial | Facility | 33 | 33 | $107.69 | $3,554 |
| 43235 Upper GI Endoscopy | Facility | 31 | 31 | $88.42 | $2,741 |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Office | 30 | 30 | $333.96 | $10K |
By year: 2022 $205K for 1,696 services; 2023 $231K for 1,650 services; 2024 $222K for 1,581 services.
Medicare prescription drug claims, 2024
In 2024, the drug Michael J Ryan prescribed most often to Medicare patients was Sucralfate, with 210 prescriptions and refills. In total Michael J Ryan wrote 1,856 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Sucralfate Generic | 210 | 448 | 79 | $17K |
| Omeprazole Generic | 196 | 515 | 61 | $2,444 |
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 144 | 144 | 141 | $1,942 |
| Pantoprazole Sodium Generic | 92 | 250 | 31 | $1,493 |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 76 | 76 | 75 | $4,673 |
| Ursodiol Generic | 67 | 156 | 21 | $12K |
| Esomeprazole Magnesium Generic | 62 | 167 | 22 | $2,922 |
| Peg-3350 And Electrolytes Peg3350/Sod Sulf,bicarb,cl/Kcl | 54 | 54 | 54 | $727 |
| Azathioprine Generic | 43 | 73 | Under 11 | $3,277 |
| Mounjaro Tirzepatide | 40 | 46 | Under 11 | $47K |
| Gavilyte-C Peg3350/Sod Sulf,bicarb,cl/Kcl | 39 | 39 | 39 | $653 |
| Linzess Linaclotide | 38 | 48 | Under 11 | $25K |
| Xifaxan Rifaximin | 37 | 43 | Under 11 | $115K |
| Tacrolimus Generic | 31 | 74 | Under 11 | $5,900 |
| Furosemide Generic | 28 | 51 | Under 11 | $85.14 |
Brand drugs: - claims; generic drugs: 1,346 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael J Ryan $86K ($86K in general payments such as food, travel and fees) from 21 companies. The largest payer was Ipsen Biopharmaceuticals, Inc with $36K.
| Company | Payments | Amount |
|---|---|---|
| Ipsen Biopharmaceuticals, Inc IPN.PA | 20 | $36K |
| Novo Nordisk Inc NVO | 15 | $23K |
| Madrigal Pharmaceuticals MDGL | 17 | $16K |
| Intercept Pharmaceuticals, Inc. | 9 | $6,966 |
| Gilead Sciences, Inc. GILD | 21 | $1,752 |
| Abbvie Inc. ABBV | 19 | $362 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 9 | $211 |
| Ardelyx, Inc. ARDX | 7 | $150 |
| Regeneron Healthcare Solutions, Inc. REGN | 4 | $97.88 |
| Janssen Biotech, Inc. JNJ | 4 | $83.1 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.